New

Market Access and Reimbursementof Innovative Medical Devices and IVD in Europe

Professional management: Dr. Tilo Mandry, Mr. Michael Weisser
Print version

Share a colleague:

Ensure the commercial success of your product! Set the right course during development Managers & senior staff from companies that intend to bring innovative medical devices or in vitro diagnostics (IVD) to the European markets are invited to join this essential webinar. The developers of such products face two major challenges: Strict safety and efficacy...Continue reading

Ensure the commercial success of your product!

Set the right course during development

Managers & senior staff from companies that intend to bring innovative medical devices or in vitro diagnostics (IVD) to the European markets are invited to join this essential webinar.

The developers of such products face two major challenges: Strict safety and efficacy requirements must be met to bring the innovation to market at all.

At the same time, it has become difficult to get an innovative medical device or IVD reimbursed by the European public healthcare systems, as they place high demands on demonstrating clinical benefit.

This webinar shows how to meet the requirements for both market access and successful commercialization through timely planning. The focus is on the right study design, which is crucial for obtaining the CE mark and for commercial success.

Case studies will be used to show how innovative medical devices and IVD can be successfully brought to European patients, what role the CE mark plays in commercialization, and how the major European countries differ in terms of benefit assessment.

Close
Date:  Coming soon.
The course will be scheduled based on the level of interest

Interested? Click here

    Course location: Virtual Webinar
    Duration: One hour
    Hours: 15:00 - 16:00
    Credits: 0
    Course Language: English

    Have a question? We have the answer

    Issues to be covered

    • Overview of the European Med Tech market (market size, key countries, health economic key data (spending on health care, etc.)
    • CE-Mark to receive market access and the meaning of reimbursement
    • Pathways for reimbursement in the European key countries (Germany, France, UK, Spain, Italy):
    • Health Technology Assessment Procedures
    • Reimbursement In the in-patient sector: purchasing power of hospitals, reimbursement via DRG, reimbursement medical devices via pathways for highly innovative products
    • Reimbursement in the out-patient sector: procedure to get listed in the directory for reimbursed medical devices and auxiliary goods. Pathways for innovative medical devices etc.

    Who should attend

    Medium-sized medical device companies with an existing medical device portfolio or with medical device prototypes in the late development phase (about one to two years before product launch). Companies with little or no experience of reimbursement in Europe.

    About The Lecturer

    Tilo Mandry
    Tilo Mandry, Lead International Liaison Manager, IGES, supports international medical
    Read more
    Michael Weisser
    Michael Weisser, CEO of AiM (an IGES Group company), has
    Read more

    Leave a Reply